丹麦人群中低密度脂蛋白与全因及病因特异性死亡率的关联:前瞻性队列研究
该研究基于丹麦哥本哈根普通人群队列,2003-15年招募108 243名20-100岁个体,中位随访9.4年,11 376人(10.5%)死亡。采用限制性立方样条和Cox回归分析发现,LDL-C与全因死亡呈U型关联:与LDL-C 3.4-3.9 mmol/L(132-154 mg/dL)相比,LDL-C <1.8 mmol/L(<70 mg/dL)者全因死亡风险HR 1.25(95%CI 1.15-1.36),LDL-C >4.8 mmol/L(>189 mg/dL)者HR 1.15(95%CI 1.05-1.27)。全因死亡风险最低的LDL-C浓度为3.6 mmol/L(140 mg/dL),接受降脂治疗者为2.3 mmol/L(89 mg/dL);LDL-C升高与心肌梗死风险增加相关。
要点
- 普通人群中LDL-C与全因死亡呈U型关联,过低(<1.8 mmol/L)和过高(>4.8 mmol/L)均增加全因死亡风险。
- 与LDL-C 3.4-3.9 mmol/L相比,<1.8 mmol/L者全因死亡HR 1.25(95%CI 1.15-1.36),>4.8 mmol/L者HR 1.15(95%CI 1.05-1.27)。
- 全因死亡风险最低的LDL-C浓度为3.6 mmol/L(140 mg/dL);接受降脂治疗者为2.3 mmol/L(89 mg/dL)。
- LDL-C任何程度的升高均与心肌梗死风险增加相关,但心血管死亡未见类似U型关联。
- 该U型关联在男女、各年龄组以及癌症和其他死亡中均可见。
适用人群与场景
- 丹麦普通人群,随机选自丹麦国家民事登记系统,年龄20-100岁,2003-15年招募,中位随访9.4年。
- 原文未提及急诊或ICU场景的专门适用人群。
诊断标准与关键阈值
- 原文未提及诊断标准或治疗阈值;仅报告LDL-C与死亡风险的关联分析界值:参照组LDL-C 3.4-3.9 mmol/L(132-154 mg/dL,第61-80百分位),低值组<1.8 mmol/L(<70 mg/dL,第1-5百分位),高值组>4.8 mmol/L(>189 mg/dL,第96-100百分位)。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:前瞻性队列研究;样本量108 243人,单中心(哥本哈根普通人群研究),中位随访9.4年,死亡11 376人(10.5%)。
- 主要终点:全因死亡与LDL-C呈U型关联;与LDL-C 3.4-3.9 mmol/L相比,<1.8 mmol/L者多变量校正HR 1.25(95%CI 1.15-1.36),>4.8 mmol/L者HR 1.15(95%CI 1.05-1.27)。
- 全因死亡风险最低的LDL-C浓度:总体及未接受降脂治疗者为3.6 mmol/L(140 mg/dL),接受降脂治疗者为2.3 mmol/L(89 mg/dL)。
- 次要终点:癌症和其他死亡可见类似U型关联,心血管死亡未见;LDL-C任何升高均与心肌梗死风险增加相关。
- 亚组:男女、各年龄组结果相似。
证据类型、等级与局限
- 证据类型:前瞻性队列研究;原文未给出证据等级或推荐强度。
- 局限:观察性设计不能推断因果;单中心(丹麦普通人群);原文未提及其他局限。
对床旁实践的改变
- 该研究提示在普通人群中评估LDL-C与死亡风险时需注意U型关联,过低LDL-C(<1.8 mmol/L)亦与全因死亡风险增加相关,但此为非因果性观察结果,不能据此改变降脂治疗目标。
- 接受降脂治疗者最低死亡风险对应LDL-C 2.3 mmol/L(89 mg/dL),未治疗者为3.6 mmol/L(140 mg/dL),提示适用人群不同,解读时需区分是否接受降脂治疗。
- LDL-C升高与心肌梗死风险增加相关,支持对高LDL-C人群的心血管风险评估。
- 不适用于急诊或ICU急性期决策;原文未提供急诊/ICU场景数据。
指南或共识出处
- 原文未提及指南或共识名称;研究发表于BMJ。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To determine the association between levels of low density lipoprotein cholesterol (LDL-C) and all cause mortality, and the concentration of LDL-C associated with the lowest risk of all cause mortality in the general population.
DESIGN: Prospective cohort study.
SETTING: Denmark; the Copenhagen General Population Study recruited in 2003-15 with a median follow-up of 9.4 years.
PARTICIPANTS: Individuals randomly selected from the national Danish Civil Registration System.
MAIN OUTCOME MEASURES: Baseline levels of LDL-C associated with risk of mortality were evaluated on a continuous scale (restricted cubic splines) and by a priori defined centile categories with Cox proportional hazards regression models. Main outcome was all cause mortality. Secondary outcomes were cause specific mortality (cardiovascular, cancer, and other mortality).
RESULTS: Among 108 243 individuals aged 20-100, 11 376 (10.5%) died during the study, at a median age of 81. The association between levels of LDL-C and the risk of all cause mortality was U shaped, with low and high levels associated with an increased risk of all cause mortality. Compared with individuals with concentrations of LDL-C of 3.4-3.9 mmol/L (132-154 mg/dL; 61st-80th centiles), the multivariable adjusted hazard ratio for all cause mortality was 1.25 (95% confidence interval 1.15 to 1.36) for individuals with LDL-C concentrations of less than 1.8 mmol/L (<70 mg/dL; 1st-5th centiles) and 1.15 (1.05 to 1.27) for LDL-C concentrations of more than 4.8 mmol/L (>189 mg/dL; 96th-100th centiles). The concentration of LDL-C associated with the lowest risk of all cause mortality was 3.6 mmol/L (140 mg/dL) in the overall population and in individuals not receiving lipid lowering treatment, compared with 2.3 mmol/L (89 mg/dL) in individuals receiving lipid lowering treatment. Similar results were seen in men and women, across age groups, and for cancer and other mortality, but not for cardiovascular mortality. Any increase in LDL-C levels was associated with an increased risk of myocardial infarction.
CONCLUSIONS: In the general population, low and high levels of LDL-C were associated with an increased risk of all cause mortality, and the lowest risk of all cause mortality was found at an LDL-C concentration of 3.6 mmol/L (140 mg/dL).
参考来源
- Johannesen CDL, Langsted A, Mortensen MB, et al. Association between low density lipoprotein and all cause and cause specific mortality in Denmark: prospective cohort study. BMJ. 2020. PMID: 33293274. doi:10.1136/bmj.m4266
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。